HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

China Microbial Transglutaminase Market Size & Outlook, 2025-2033


China Microbial Transglutaminase Market Insights

  • As per Reed Intelligence insights, the China Microbial Transglutaminase Market stood at USD 15.01 Million in 2024 and is anticipated to grow to USD 36.51 Million by 2033.
  • The China market is expected to advance at a CAGR of 10.3% from 2026 through 2033.
  • In 2024, Streptomyces Mobaraense accounted for the highest share of the By Source market size.
  • During the forecast period, Streptoverticillium Griseocarneum is set to register the highest growth, making it the most lucrative By Source segment.

Other Key Findings


  • In 2024, China represented 11% of the overall global Microbial Transglutaminase Market size.
  • United States is projected to lead the global Microbial Transglutaminase Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • China is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 36.3 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 15.01 Million
Market Size In 2033 USD 36.51 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 10.3% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports